Actinic Keratosis
📧 Sign up to get email alerts when something new happens for Actinic Keratosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-07Clinical Trial Update: Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients [Phase 2]
A Phase 2 trial evaluating immunotherapy after organ transplantation to prevent skin cancer in transplant recipients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands [Phase 4]
Phase 4 clinical trial evaluating tirbanibulin 1% ointment for actinic keratosis on the back of the hands has been withdrawn.
-
EMA withdrawal · 2020-07-31EMA Withdrawn: Picato (Ingenol mebutate) — LEO Laboratories Ltd.
EMA has withdrawn Picato (ingenol mebutate) from the market in Europe.
-
CLINICAL_TRIALS withdrawal · 2017-11-07Clinical Trial Update: Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp [Phase 3]
Phase 3 study of Levulan with blue light for actinic keratosis on the face or scalp was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-05Clinical Trial Update: Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses [Phase 2, Phase 3]
This ClinicalTrials.gov entry indicates that a Phase 2/Phase 3 trial of celecoxib to prevent skin cancer in patients with actinic keratoses …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.